- Where are Leapfrog’s 11 straight-‘A’ hospitals?
- Where are Leapfrog’s 5 ‘F’ hospitals?
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS Health beats the Street with $2.9B in Q1 profit
- Rethinking DSOs: Challenging common misconceptions in modern dentistry
- WakeMed CEO says years of talks led to Atrium deal: ‘We’re the smallest health system of the competitive world now in North Carolina’
- 9 behavioral health facility and service closures, layoffs in 2026
- The new class of opioids: 4 things to know
- Maine health system unveils unified brand
- Physicians in Congress propose Medicare payment overhaul
- 2 men sentenced in $522M fraud, kickback scheme
- What 3 ASC leaders are saying about cardiology’s race to outpatient
- Hospital at home linked to better outcomes: 7 notes
- Long-established Florida physician practice acquired
- Facilitating Access to Trump Accounts
- HCA Tennessee hospital taps COO
- WellSpan Health to open 4-room ASC in Pennsylvania
- Colorado hospital names new CEO
- Yale New Haven hospital president to retire
- Ascension Tennessee hospital names COO
- Nurses fret AI overreliance could erode care, call for more guardrails
- Surgery Partners increases same-facility revenue by 4% in Q1: 10 notes
- Fixing Failures to Communicate
- Dr. Nisha D’Silva installed as president of the American Association for Dental, Oral and Craniofacial Research
- PDS Health, CareQuest partner to expand blood pressure screenings in dental offices
- 5 hospitals, health systems investing in ASCs
- Bankruptcy, PE debt and a $3.9B Ascension deal: A 30-year breakdown of AmSurg
- Henry Schein increases global dental sales by 9% in Q1: 7 notes
- Heartland Dental expands in 7 states
- Ohio woman charged with practicing unlicensed dentistry
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- 15 physician deals in 40 days
- Psych hospital eases security tool restrictions after violent incidents
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- TriHealth hospital hit with $10M verdict in psychiatric unit death
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- From 1st-in-state to 1st-in-world: 5 surgical milestones to know
- California hospitals sue Anthem over out-of-network care policy
- 3 dental mergers, acquisitions in April
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- HHS outlines plan to ‘curb psychiatric overprescribing’: 5 things to know
- Former Oklahoma dental assistant sentenced to prison for assaulting patients
- Statement on Proposing Semiannual Reporting
- Transforming Behavioral Healthcare Delivery through the Collaborative Care Model
- Wellstar partners with BD to implement AI-driven medication management system
- Tennessee dental practice to close due to financial strain
- Listen to the Latest ‘KFF Health News Minute’
- Lifepoint Health taps new vice president of finance from Acadia
- UnitedHealthcare to reduce prior auth requirements by 30%
- ‘Retire one-and-done interventions’: Wellstar achieves 40% drop in physician distress
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Why state dental boards are scrutinizing DSOs
- Child Mind Institute names chief clinical officer
- UMass Memorial behavioral health provider to lay off 78 employees
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- American Hospital Association, West Health Institute partner to help health systems scale new tech
- Alignment CEO expects short delay for CMS' proposed risk adjustment changes
- WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Nearly half of reproductive age women with Medicaid coverage live in states restricting abortion: KFF
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
- After March cuts, Novartis trims another 60 roles at US headquarters
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
- Orchestrating Affordability: The Critical New Role of the Health Plan
- The Case for a More Proactive Payment Integrity Program
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














